Algo muy normal en la microbiología europea
Clinical Microbiology and Infection
Volume 16, Issue 10, pages 1511–1517, October 2010
The use of human immunodeficiency virus resistance tests in clinical practice
F. Ceccherini-Silberstein has received funds for attending symposia, speaking and organizing educational activities from Abbott, Merck Sharp & Dohme, Janssen Cilag, and Virco. V. Calvez and C.-F. Perno have received funds for attending symposia, speaking, organizing educational activities, grant research support, consultancy and advisory board membership, from Abbott, Boehringer Ingelheim, Bristol Myers Squibb, Gilead, Merck Sharp & Dohme, Janssen Cilag, Pfizer, Tibotec, Roche, and ViiV. V. Cento has nothing to declare.
Y la verdad, antes de deducir algo de este artículo tendría que leer mucho más. Tanto apoyo comercial me hace decidir no leerlo y buscar otros artículos.
No hay comentarios:
Publicar un comentario